213
panel
Opening Plenary | Part 1: A Conversation with Maxine Waters, US Representative, California | Part 2: The Future of Brain Health
This session will open with a conversation with Maxine Waters, US Representative, California, fo
llowed by a panel discussion.
+ Read More
panel
Gut Feeling: Food, Microbiome, and Disease Prevention
As researchers continue to study the microbiome, it's clear that our gut is a powerful tool in d
isease prevention and treatment. How can understanding the microbiome influence the way we eat and nourish our bodies?
+ Read More
panel
A Journey to the Cutting Edge of Bioscience: Cancer as a Case Study
Today, the line between clinical practice and clinical research is becoming blurred, largely tha
nks to investments in data, the existence of highly networked centers of excellence, and the work of research communities.
+ Read More
panel
Lunch Program | Part 1: A Conversation with Bill Cassidy, MD, US Senator, Louisiana | Part 2: A Conversation with Nancy Pelosi, Speaker, US House of Representatives | Part 3: Walking the Drug-Pricing Tightrope
This session will open with a conversation with Bill Cassidy, MD, US Senator, Louisiana, followe
d by a conversation with Nancy Pelosi, Speaker, US House of Representatives, and a panel discussion.
+ Read More
panel
Closing Networking Reception
panel
Networking Break
panel
Asset Owners’ Outlook: Priorities and Perspectives on Long-Term Value Creation (Invite only)
Global asset owners today have their work cut out for them as they consider capital allocation d
ecisions.
+ Read More
panel
Global Investors’ View: China (Invite only)
Beijing has gone above and beyond its normal policy practices to boost investor confidence. Stim
ulus packages, interest rate cuts, and local bond issuances are several of the levers it pulled to boost domestic economic activity.
+ Read More
panel
Forum for Family Asset Management Roundtable: How Global Shifts are Reshaping Family Office Allocations (Invite only)
In today’s global environment, how are family offices recalibrating investment strategies amid g
lobal shifts, rising protectionism, regulatory changes, and macroeconomic uncertainty?
+ Read More
panel